Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • yl01
    Member
    • Aug 2012
    • 25

    #1

    GATK UnifiedGenotyper question

    Hello all,

    I was setting up my human exome sequencing analysis pipeline mostly according to the How-to/exome analysis manual. My question is in the producing raw SNP call step using UnifiedGenotyper. From the best practises on GATK web site I know that it is better to give multiple BAM files to UnifiedGenotyper at the same time and output one multi sample VCF file. However, my impression from the How-to and other exome pipelines is that giving one file to UnifiedGenotyper each time to obtain one single sample VCF file is more common. And I also find it is easier to manage the different files when I have one VCF file for each individual. I did a comparison of the two methods and number of obtained SNPs are different. So what is the benefit of calling variants using UnifiedGenotyper with multiple BAM files?
  • vivek_
    PhD Student
    • Jul 2012
    • 164

    #2
    Here is a link on this discussion from the GATK forums.



    When you call each sample independently the genotyper will not output homozygous reference calls. Whereas these calls will be output in multisample calling if atleast one of the samples being called has indication of a non reference allele present at that location.

    This could explain why you are seeing more variants when calling the samples together.

    I normally do multisample calling when I have family data as it makes subsequent downstream analysis easier.

    Comment

    • yl01
      Member
      • Aug 2012
      • 25

      #3
      Thank you vivek_ for poiting out the link. It answered my question well. The short answer seems to be multiple sample calling is always better.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...